Search Results for:
-
Oxford BioTherapeutics Inks Target Validation Pact with BI
The shape of the deal is markedly different from the headline-grabbing pact involving five antibody and antibody-drug conjugate (ADC) programs it entered last year with Menarini Group, of Florence, Italy. (See BioWorld Today, Oct. 30, 2012.) That deal is focused on what for OBT are relatively late-stage programs, which means they will yield investigational new drug application (IND) filings in two years or lessBy Cormac Sheridan | BioWorld Today | Wednesday, May 1, 2013 -
AVEO Drops on Possibility of Second Phase III Trial
The committee also will discuss Delcath Systems Inc.'s new drug application for the Melblez kit, a drug/device combination that uses the Delcath Hepatic Delivery System to administer Melblez (melphalan) to treat unresectable ocular melanoma that's metastatic to the liver.By Mari Serebrov | BioWorld Today | Wednesday, May 1, 2013 -
Clinic Roundup
Celltrion Inc., of Incheon, South Korea, said it received investigational new drug application approval from the UK's Medicines and Healthcare products Regulatory Agency to start a Phase I trial of CT-P27, an influenza antibody shown to have efficacy for pandemic and seasonal flu strains, including various subtypes of influenza virusesBioWorld Today | Tuesday, April 30, 2013 -
Other News To Note
Gilead Sciences Inc., of Foster City, Calif., said it received complete response letters (CRLs) from the FDA for its new drug applications for elvitegravir and cobicistat to use as part of HIV treatment regimensBioWorld Today | Tuesday, April 30, 2013 -
Clinic Roundup
R-Tech Ueno, of Tokyo, said it submitted an investigational new drug application to start Phase I/II trials of its recombinant human serum albumin-containing ophthalmic solution, in development for severe dry eyeBioWorld Today | Monday, April 29, 2013 -
Avaxia's Barbara Fox Stays on the Run at BIO 2013
She cited FDA clearance of the company's investigational new drug application in November 2012 as a key milestone "that opened a lot of doors for usBy Marie Powers | BioWorld Today | Monday, April 29, 2013 -
Regulatory Harmonization on the Horizon for Taiwan, China
Theoretically, if the global trial is successful, a new drug application (NDA) can be submitted in ChinaBy Dave Silver | BioWorld Today | Monday, April 29, 2013 -
Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: Feb. 1 - April 25, 2013
Eisai transferred the new drug application to Valeant, but retained rights to Targretin outside the U.SBioWorld Insight | Monday, April 29, 2013 -
Biotechnology Company Deals With Other Biotechnology Companies: Feb. 1 - April 25, 2013
Total Value in 2013: $5,960.77M* Number of Deals in 2013: 93 Company (Location) Company (Location) Value (M) Type/Product Area Terms/Details Date FEBRUARY Ablynx NV (Ghent, Belgium) Spirogen Ltd. (London) ND Research collaboration to evaluate the potential of a cancer drug conjugate combining Spirogen's cytotoxic drugs, pyrrolobenzodiazepines and associated linker technology, with Nanobodies generated Ablynx will provide access to Nanobodies against an undisclosed target, and Spirogen willBioWorld Insight | Monday, April 29, 2013 -
Pharma: Other News To Note
In October 2012, the FDA granted approval of Actavis' abbreviated new drug applicationBioWorld Today | Friday, April 26, 2013 -
Other News To Note
An investigational new drug application filing is anticipated for 2015...Assuming successful completion of the study, NIDA plans to file an investigational new drug application for a final larger studyBioWorld Today | Thursday, April 25, 2013 -
Broken China Seeks to Mend, but Still Far from Home Plate
In our national policy, we do not have a very specific definition about what the new drug application process will be" for those compoundsBy Randy Osborne | BioWorld International | Wednesday, April 24, 2013 -
ActoGeniX Series B to Move IBD Program to IND Stage
ActoGeniX NV closed a Series B equity financing round, raising €€10.7 million (US$14 million) to move its ActoBiotics program to the investigational new drug application (IND) stage in a second indication of inflammatory bowel disease (IBDBy Marie Powers | BioWorld International | Wednesday, April 24, 2013 -
BIND's Accurin Platform Lands $200M AstraZeneca Partnership
BIND will develop the Accurin and do the initial screening and will work with AstraZeneca on pre-investigational new drug application activities, then will handle manufacturing during the development phaseBy Jennifer Boggs | BioWorld International | Wednesday, April 24, 2013 -
Other News To Note
plc, of Dublin, Ireland, said the FDA approved a supplemental new drug application to add Chemport Inc...The RAC review is a required step for a product involving gene therapy vectors, and most of the material will be used in the subsequent investigational new drug application filingBioWorld International | Wednesday, April 24, 2013 -
Other News To Note
plc, of Bedminister, N.J., and Dublin, Ireland, said the FDA accepted its supplemental new drug application for Vascepa (icosapent ethyl) capsules for use as an adjunct to diet in treating high triglycerides...Curemark LLC, of Rye, N.Y., said it will begin filing a new drug application (NDA) for its CM-AT autism treatment following a successful pre-NDA meeting with the FDABioWorld Today | Wednesday, April 24, 2013 -
GW Sets Terms for U.S. IPO; $40M for Cannabinoid Drugs
sites. (See BioWorld Today, June 23, 2010.) Top-line results from two Phase III trials in cancer pain are due in 2014 and, pending a positive outcome, are expected to serve as the basis for a new drug application in the U.S., as well as for regulatory submissions in other markets...Ltd., of Tokyo, under the terms of a 2007 deal valued at up to $273 million. (See BioWorld Today, Feb. 15, 2007.) GW also will pursue an MS spasticity indication in the U.S., with an investigational new drugBy Jennifer Boggs | BioWorld International | Wednesday, April 24, 2013 -
Broken China Seeks to Mend, but Still Far from Home Plate
In our national policy, we do not have a very specific definition about what the new drug application process will be" for those compoundsBio Perspectives | Tuesday, April 23, 2013 -
Broken China Seeks to Mend, but Still Far from Home Plate
In our national policy, we do not have a very specific definition about what the new drug application process will be" for those compoundsBy Randy Osborne | BioWorld Today | Tuesday, April 23, 2013 -
BIND's Accurin Platform Lands $200M AstraZeneca Partnership
BIND will develop the Accurin and do the initial screening and will work with AstraZeneca on pre-investigational new drug application activities, then will handle manufacturing during the development phaseBy Jennifer Boggs | BioWorld Today | Tuesday, April 23, 2013
Category
Current Filters
- xdrug application
Related Keywords
Categories
- x BioWorld Today (7467)
- x BioWorld Insight (565)
- x BioWorld International (483)
- x Bio Perspectives (114)
- x State of the Industry Report (45)
- x BioWorld Snapshots (16)
- x Top 25 Drug Report (12)
- x BioWorld Genomics Review (12)
- x Biotech Innovations (11)
- x RNAi Report (2)
- x Market-Leading Biotech Drugs (2)
- x Executive Compensation Report (1)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.